Dr. Surabhi Madhwal Atreja, MD

Dr. Atreja practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Atreja's NPI, 1528233418, was assigned on April 23, 2008. Dr. Atreja graduated from Baba Raghav Das Medical College in 1999. Dr. Atreja holds California license C172091.

Dr. Atreja's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Atreja's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Atreja to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atreja practices. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Atreja's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Atreja is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Atreja's licenses on file in 4 states: California, New Jersey, New York and Ohio.

Dmand AI lists aneurysm, angioplasty, atherosclerosis, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension and circulation problems among the conditions Dr. Atreja treats.

CMS data shows 1,123 Medicare services from Dr. Atreja across 16 procedure codes in 2024, for 477 Medicare patients. Medicare paid $72,737 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 477 Medicare patients who saw Dr. Atreja in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atreja's median patient age at 67, with 43% women.

In 2024, Dr. Atreja wrote 1,357 Medicare Part D claims for 184 patients. 81% of them were for generic drugs. CMS names the drug for 1,186 of them, across 22 drugs with 11 or more claims each, at $240,330 in total drug cost. In 2023, CMS named 874 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Atreja for performance year 2024, reported as part of a group. Dr. Atreja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Atreja as offering telehealth. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Atreja, more than 44% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Atreja in 2024.

CMS Open Payments shows 182 general payments to Dr. Atreja from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Recor Medical Inc paid the most, $21,746.

Dr. Atreja graduated from Baba Raghav Das Medical College in 1999. Dr. Atreja is a member of ACC.

Dr. Atreja is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.